Fact based stock research
Bio-Rad Laboratories (NYSE:BIO)

Bio-Rad Laboratories stock research in summary

Bio-Rad Laboratories shares have a market-typical stock price level. They are safely financed and are good value, but show below average growth. We recommend evaluating whether the future of the company Bio-Rad Laboratories is typical for this industry which the market average price level of the shares suggests. If you believe that the future of the company is above average, that could be an argument for buying the shares and vice versa.

Latest Obermatt Ranks


Value Rank	53
Growth Rank	39
Safety Rank	94
Combined Rank	78

Country	USA
Industry	Life Sciences Tools & Services
Index	S&P MIDCAP
Size class	Large

September 13, 2019. Stock data may be delayed. Login to get the most recent research.

Add to Watchlist

Filter Similar Stocks

Similar Top 10

Google: Bio-Rad Laboratories

News	Videos
Wikipedia about Bio-Rad Laboratories	Management
Employee Satisfaction	Customer Satisfaction

Research History: Bio-Rad Laboratories

RESEARCH HISTORY	2016	2017	2018	2019
VALUE
VALUE	51	35	71	53
GROWTH
GROWTH	54	54	38	39
SAFETY
SAFETY	95	42	94	94
COMBINED
COMBINED	74	50	88	78

Last update of Combined Rank: 13-Sep-2019. Financial reporting date used for calculating ranks: 30-Jun-2019. Stock research history is based on the Obermatt Method. The higher the rank, the better Bio-Rad Laboratories is in the corresponding investment strategy.

Value Metrics in Detail

VALUE METRICS	2016	2017	2018	2019
PRICE VS. REVENUES (P/S)
PRICE VS. REVENUES (P/S)	79	64	59	44
PRICE VS. PROFITS (P/E)
PRICE VS. PROFITS (P/E)	42	34	100	96
PRICE VS. CAPITAL (Market-to-Book)
PRICE VS. CAPITAL (Market-to-Book)	60	61	62	58
DIVIDEND YIELD
DIVIDEND YIELD	1	1	1	1
CONSOLIDATED RANK: VALUE
CONSOLIDATED RANK: VALUE	51	35	71	53

Last update of Value Rank: 13-Sep-2019. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Bio-Rad Laboratories; except for dividend yield where the rank is higher, the higher the yield.

Growth Metrics in Detail

GROWTH METRICS	2016	2017	2018	2019
REVENUE GROWTH
REVENUE GROWTH	29	36	13	24
PROFIT GROWTH
PROFIT GROWTH	55	55	33	39
STOCK RETURNS
STOCK RETURNS	95	80	86	69
CONSOLIDATED RANK: GROWTH
CONSOLIDATED RANK: GROWTH	54	54	38	39

Last update of Growth Rank: 30-Jun-2019. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Bio-Rad Laboratories.

Safety Metrics in Detail

SAFETY METRICS	2016	2017	2018	2019
LEVERAGE
LEVERAGE	55	46	56	50
REFINANCING
REFINANCING	77	63	74	64
LIQUIDITY
LIQUIDITY	83	82	81	94
CONSOLIDATED RANK: SAFETY
CONSOLIDATED RANK: SAFETY	95	42	94	94

Last update of Safety Rank: 6-Sep-2019. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Bio-Rad Laboratories and the more cash is available to service its debt.

Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Bio-Rad Laboratories from September 13, 2019.

We invest in our stock tips ourselves and openly publish the returns of our portfolio. That's how much we believe in our stock research. Subscribe to the top 10 stocks for 100 markets conveniently by e-mail.